Brazil Approves Its First Local Rival to Ozempic

BRAZIL · ECONOMY Key Facts —The approval: Brazil’s health regulator cleared Ozivy, the country’s first home-grown version of the drug behind Ozempic. —The maker: It is produced by EMS, one of Brazil’s largest pharmaceutical companies. —Why now: The move follows the March expiry of the patent on semaglutide, the active ingredient. —The use: Ozivy is […] The post Brazil Approves Its First Local Rival to Ozempic appeared first on The Rio Times .

Go to News Site